GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $559,000 | +15.5% | 12,678 | 0.0% | 0.10% | +1.1% |
| Q3 2021 | $484,000 | -4.2% | 12,678 | 0.0% | 0.10% | -5.9% |
| Q2 2021 | $505,000 | +11.0% | 12,678 | -0.5% | 0.10% | +4.1% |
| Q1 2021 | $455,000 | +19.4% | 12,741 | +22.9% | 0.10% | +9.0% |
| Q4 2020 | $381,000 | -8.2% | 10,365 | -5.9% | 0.09% | -22.6% |
| Q3 2020 | $415,000 | -11.7% | 11,013 | -4.5% | 0.12% | -18.4% |
| Q2 2020 | $470,000 | +4.0% | 11,534 | -3.3% | 0.14% | -9.0% |
| Q1 2020 | $452,000 | -28.5% | 11,928 | -11.3% | 0.16% | +2.6% |
| Q4 2019 | $632,000 | +6.4% | 13,451 | -3.4% | 0.15% | +3.4% |
| Q3 2019 | $594,000 | -2.1% | 13,921 | -8.2% | 0.15% | -5.8% |
| Q2 2019 | $607,000 | -15.8% | 15,161 | -12.3% | 0.16% | -13.9% |
| Q1 2019 | $721,000 | – | 17,279 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |